1.
Nature
; 602(7895): 33, 2022 02.
Article
in English
| MEDLINE
| ID: mdl-35105995
Subject(s)
Antiviral Agents/economics , Antiviral Agents/supply & distribution , COVID-19 Drug Treatment , COVID-19 Vaccines/supply & distribution , COVID-19/prevention & control , Developing Countries , COVID-19/economics , COVID-19/immunology , COVID-19/mortality , Cytidine/analogs & derivatives , Cytidine/economics , Cytidine/supply & distribution , Developed Countries/economics , Developing Countries/economics , Drug Costs , Healthcare Disparities/economics , Healthcare Disparities/statistics & numerical data , Hospitalization/statistics & numerical data , Humans , Hydroxylamines/economics , Hydroxylamines/supply & distribution , Lactams/economics , Lactams/supply & distribution , Leucine/economics , Leucine/supply & distribution , Licensure , Nitriles/economics , Nitriles/supply & distribution , Proline/economics , Proline/supply & distribution
2.
Nature
; 599(7883): 25-27, 2021 11.
Article
in English
| MEDLINE
| ID: mdl-34732862